Key to formulary
Green medicines
-
Green
- Appropriate for initiation and ongoing prescribing in both primary and secondary care.
- Generally, little or no routine drug monitoring is required.
-
Green (restricted)
-
Appropriate for initiation and ongoing prescribing in both primary and secondary care provided:
- Additional criteria specific to the medicine or device are met, or
- The medicine or device is used following the failure of other therapies as defined by the relevant LSCMMG pathway.
- Generally, little or no routine drug monitoring is required.
-
Appropriate for initiation and ongoing prescribing in both primary and secondary care provided:
Amber medicines
-
Amber 0
- Suitable for prescribing in primary care following recommendation or initiation by a specialist.
- Little or no specific monitoring required.
- Patient may need a regular review, but this would not exceed that required for other medicines routinely prescribed in primary care.
- Brief prescribing document or information sheet may be required.
When recommending or handing over care, specialists should ask primary care prescribers to take over prescribing responsibility, and should give enough information about the indication, dose, monitoring requirements, use outside product licence and any necessary dose adjustments to allow them to confidently prescribe.
-
Amber 1 - Amber level 1 (with shared care)
- Suitable for prescribing in primary care following recommendation or initiation by a specialist.
- Minimal monitoring required.
- Patient may need a regular review, but this would not exceed that required for other medicines routinely prescribed in primary care.
- Full prior agreement about patient’s on-going care must be reached under the shared care agreement.
-
Amber 2 - Amber level 2 (with shared care and enhanced service)
- Initiated by specialist and transferred to primary care following a successful initiation period.
- Significant monitoring required on an on-going basis.
- Full prior agreement about patient’s on-going care must be reached under the shared care agreement.
- Suitable for enhanced service.
Red medicines
-
Red
- Medicine is supplied by the hospital for the duration of the treatment course.
- Primary care initiation or continuation of treatment is not recommended unless exceptional circumstances such as specialist GP.
Primary care prescribers may prescribe RED medicines in exceptional circumstances to patients to ensure continuity of supply while arrangements are made to obtain on going supplies from secondary care.
Grey medicines
- Grey
- Medicines which have not yet been reviewed or are under the review process.
- GPs and specialists are recommended not to prescribe these drugs.
- Grey N.P. - Grey not prioritised
- Low priority for review.
- GPs and specialists are recommended not to prescribe these drugs and to submit an application to LSCMMG if they wish to use.
Black medicines
- Black
- NOT recommended for use by the NHS in Lancashire.
- Includes medicines that NICE has not recommended for use and terminated technology appraisals, unless there is a local need.
Blue medicines
-
Blue
- Refer to the Lancashire & South Cumbria Medicines Management Group Guidelines
Medicine Recommendations
Sorry, no there are no medicines to display.